Sygnis SA (WSE:SYG)
1.350
+0.020 (1.50%)
Last updated: Jun 10, 2026, 9:00 AM CET
Sygnis Market Cap
Sygnis has a market cap or net worth of 37.85 million as of June 16, 2026. Its market cap has increased by 54.58% in one year.
Market Cap
37.85M
Enterprise Value
36.26M
Revenue
13.02M
Ranking
n/a
PE Ratio
39.21
Stock Price
1.35
Market Cap Chart
Since March 16, 2012, Sygnis's market cap has increased from 6.21M to 37.85M, an increase of 509.61%. That is a compound annual growth rate of 13.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 37.85M | -36.11% |
| Dec 30, 2025 | 59.24M | 501.78% |
| Dec 30, 2024 | 9.84M | -56.47% |
| Dec 29, 2023 | 22.62M | -56.95% |
| Dec 30, 2022 | 52.54M | 10.53% |
| Dec 30, 2021 | 47.53M | 177.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.99B |
| NEUCA | 3.24B |
| Synektik Spólka Akcyjna | 2.50B |
| Voxel | 1.24B |
| Read-Gene | 58.71M |
| Milton Essex Spólka Akcyjna | 51.41M |
| BioMaxima | 39.83M |
| Pharmena | 34.97M |